Research map / Label-efficient and robust learning / Recognition and long-tail
Unraveling Pain Levels: A Data-Uncertainty Guided Approach for Effective Pain Assessment
Read the paperCheck your idea against 108,967 papers
AI-extracted summary. Written by AI from the paper's full text. Numbers and claims can be wrong or missing context, so check the paper before you cite or build on it.
Proposes DUG-CORAL, an EDA-only ordinal regression CNN for pain intensity that uses HRV-derived subject uncertainty to scale per-subject training updates and a non-uniform task weighting for label ambiguity.
Problem
Automated pain assessment from biosignals ignores data uncertainty (subject-level stimulus-response drift and ambiguity in self-reported pain scores), which degrades accuracy of pain intensity estimation.
Approach
Estimate per-subject uncertainty as the coefficient of variation of the first principal component of HRV features (from ECG) and use it to scale that subject's gradient updates; combine with subject-wise batching/normalization and a pain-specific non-uniform weighting of CORAL binary tasks that up-weights intermediate pain transitions.
Key results
- On BioVid, DUG-CORAL reaches MAE 0.83 versus 0.90 for the prior CORN method (the paper claims a 6% improvement), though its RMSE (1.25) is worse than some baselines.
- On the Apon dataset with time-domain features, DUG-CORAL achieves MAE 0.77 / RMSE 0.98 versus CORAL 0.78 / 1.01, a marginal gain over CORAL, while SVR/RF/AdaBoosting are much worse.
- The best task-weighting scheme (V, up-weighting high-ambiguity intermediate transitions) yields lower MAE/RMSE than equal weighting on both datasets (e.g., Apon MAE 0.773 vs 0.776).
Measured effects reported in the paper
| What was changed | Where | Measured | Effect |
|---|---|---|---|
| Use the DUG-CORAL framework rather than the strongest listed baseline | Pain assessment models · BioVid | MAE: 0.90 -> 0.83 | Helped |
| Use DUG-CORAL rather than the strongest listed baseline | Pain assessment models · BioVid | RMSE: 1.16 -> 1.25 | Hurt |
| Use DUG-CORAL rather than CORAL | Apon pain assessment · Apon | MAE: 0.76 -> 0.75 | Helped |
| Use DUG-CORAL rather than CORAL | Apon pain assessment · Apon | RMSE: 0.95 -> 0.94 | Helped |
| Emphasize high-ambiguity tasks with Scheme V instead of equal task weights (ablation) | DUG-CORAL · BioVid | MAE: 0.845 -> 0.839 | Helped |
| Emphasize high-ambiguity tasks with Scheme V instead of equal task weights (ablation) | DUG-CORAL · BioVid | RMSE: 1.294 -> 1.271 | Helped |
| Emphasize high-ambiguity tasks with Scheme V instead of equal task weights (ablation) | DUG-CORAL · Apon | MAE: 0.776 -> 0.773 | Helped |
| Emphasize high-ambiguity tasks with Scheme V instead of equal task weights (ablation) | DUG-CORAL · Apon | RMSE: 0.986 -> 0.980 | Helped |
| Emphasize low-ambiguity tasks with Scheme IV instead of equal task weights (ablation) | DUG-CORAL · BioVid | MAE: 0.845 -> 0.865 | Hurt |
| Emphasize low-ambiguity tasks with Scheme IV instead of equal task weights (ablation) | DUG-CORAL · Apon | RMSE: 0.986 -> 0.996 | Hurt |
| Use the PC1 of HRV features with the [0.8, 1.2] uncertainty-factor range rather than individual HRV features (ablation) | DUG-CORAL · BioVid | MAE: 0.840, 1.311 -> 0.825, 1.262 | Helped |
| Use the PC1 of HRV features with the [0.8, 1.2] uncertainty-factor range rather than individual HRV features (ablation) | DUG-CORAL · Apon | MAE: 0.858, 1.166 -> 0.804, 1.120 | Helped |
Surprising findings
- Despite the paper's framing, the Apon gains over CORAL are small (about 0.01 MAE), far below the claimed 20% improvement over baselines, which mainly reflects weak classical baselines.
- The method's RMSE is worse than several baselines on BioVid, which the authors attribute to occasional large errors.
Limitations
- RMSE on BioVid is worse than several prior methods, suggesting occasional large prediction errors.
- Apon is a private dataset of healthy participants with thermal stimulation, limiting external validation; the clinical patient validation is only in an appendix.
- Uncertainty estimation depends on ECG-derived HRV features and fixed weight-range hyperparameters chosen empirically.
Experimental setup
Datasets: BioVid heat pain dataset (part A) Apon dataset
Benchmarks: BioVid heat pain dataset Apon dataset
Metrics: MAE RMSE
Baselines: Multi-stage ensemble classifier DDCAE SVR Domain Adaptation SVR with trajectories CORN RF AdaBoosting CORAL
Builds on: CORAL CORN homoscedastic uncertainty weighting
Closest papers by meaning
- PEACE: A Dataset of Pharmaceutical Care for Cancer Pain Analgesia Evaluation and Medication Decision (NeurIPS 2024 · similarity 0.82)
- Large-scale Training of Foundation Models for Wearable Biosignals (ICLR 2024 · similarity 0.81)
- Pharmacokinetics-Informed Neural Network for Predicting Opioid Administration Moments with Wearable Sensors (AAAI 2024 · similarity 0.81)
- Quantifying Aleatoric Uncertainty of the Treatment Effect: A Novel Orthogonal Learner (NeurIPS 2024 · similarity 0.80)
- FEEL: Quantifying Heterogeneity in Physiological Signals for Generalizable Emotion Recognition (NeurIPS 2025 · similarity 0.80)
- Bayesian Neural Controlled Differential Equations for Treatment Effect Estimation (ICLR 2024 · similarity 0.80)
Writing a paper in this area? scime draft is a free LaTeX editor with AI included, real-time co-authors and a check of your references and venue rules before you submit. It also imports OpenAI Prism projects.